Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 7/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 6/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PRKDC | P78527 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7126366 | 0.83 | L3MBTL1 (0.43) | NPC1RAB9AMAOBMAOA | |
| SCHEMBL7134471 | 0.79 | DAO (0.43) | NPC1RAB9AMAOBMAOATDP1 | |
| SCHEMBL6828965 | 0.77 | MAOB (0.40) | NPC1RAB9AMAOBMAOATDP1 | |
| SCHEMBL6829285 | 0.77 | MAOB (0.44) | RAB9AMAOBAOC3 | |
| SCHEMBL6828913 | 0.75 | MAOB (0.49) | NPC1RAB9AMAOBTDP1 | |
| SCHEMBL7131180 | 0.75 | MAOB (0.51) | NPC1RAB9AMAOBMAOATDP1 | |
| SCHEMBL7130916 | 0.75 | MAPT (0.39) | TDP1 | |
| SCHEMBL18002479 | 0.73 | MAOB (0.49) | RAB9AMAOBMAOAACHE | |
| SCHEMBL7131595 | 0.72 | MRGPRX4 (0.57) | NPC1RAB9AMAOBMAOA | |
| SCHEMBL28187890 | 0.71 | MAOB (0.57) | NPC1RAB9AMAOBMAOAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004037808-A1 | 2 - SUBSTITUTED HETEROCYCLIC COMPOUNDS AND ANTITUMOR COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2004-05-06 | — | — | WO | disclosed |